Latest Biotech News

Collaborations involving the A*STAR Genome Institute of Singapore and 10x Genomics are launching large-scale spatial transcriptomics studies analyzing up to 2,500 patient tissue samples across...

Abbott Laboratories reported a 1% dip in second quarter diagnostics revenue to $2.17 billion, pressured by falling COVID-19 test sales and China's volume-based procurement impact. Notably, core...

Biotech innovations highlight a diverse array of advancements: Theranostic efforts using AI-powered tumor microenvironment deconvolution tools, gene editing therapies for cystic fibrosis supported...

Sarepta Therapeutics has enacted a major restructuring following safety concerns related to its Duchenne muscular dystrophy gene therapy Elevidys. The company is cutting approximately 36% of its...

Researchers in the UK have reported the successful birth of eight healthy babies conceived using mitochondrial donation and pronuclear transfer techniques to prevent mitochondrial DNA disease...

Johnson & Johnson reported a record-breaking quarter exceeding $15 billion in pharmaceutical sales, despite significant declines in its blockbuster drug Stelara due to generic competition. The...

The FDA’s regulatory decisions have highlighted internal disagreements, especially regarding COVID-19 vaccines for children and gene therapy approvals. Center for Biologics Evaluation and Research...

Advances leveraging artificial intelligence (AI) are reshaping drug discovery, diagnostics, and biomanufacturing. The Baker lab announced AI techniques to drug intrinsically disordered proteins...

Research is progressing with novel biomarkers, therapies, and diagnostics addressing cardiovascular and metabolic conditions. Studies identified imidazole propionate (ImP), a gut microbiota...

Despite industry-wide challenges including tightening venture funding and regulatory uncertainty, key biotech and pharma companies are adjusting strategies to sustain growth. Novartis named a new...

Leading biopharma companies report key advances and challenges in cancer and rare disease therapeutics. Diamedica demonstrated early efficacy of DM199 in preeclampsia, an area with no approved...

Neuroscience research sees innovations ranging from brain activity imaging to understanding pain and sleep. Stanford researchers developed ultra-sensitive optical instruments using genetically...

Regulatory and policy developments continue to influence the biotech sector broadly. The UK government announced plans to reduce drug and medical device approval costs by 25% over the next decade...

Sarepta Therapeutics is undergoing a significant strategic restructuring following safety concerns related to its Duchenne muscular dystrophy (DMD) gene therapy, Elevidys. The company announced a...

Researchers in the U.K. have reported the successful birth of eight healthy babies using mitochondrial donation and pronuclear transfer to prevent mitochondrial DNA diseases. This three-person IVF...

The FDA’s Oncologic Drugs Advisory Committee reviewed GSK's Blenrep (belantamab mafodotin) for multiple myeloma, expressing concerns regarding high rates of ocular toxicity including severe vision...

A comprehensive report from the Life Sciences Workforce Collaborative and Teconomy Partners LLC shows a slowing growth rate in the US life sciences sector, with industry-wide hiring down slightly...

Thermo Fisher Scientific announced its agreement to acquire Sanofi’s Ridgefield, New Jersey sterile fill-finish and packaging site. The acquisition will broaden Thermo Fisher’s US manufacturing...

Singapore’s A*STAR and 10x Genomics announced a collaboration for the TISHUMAP project, employing high-resolution spatial transcriptomics and AI to analyze up to 2,500 clinical samples from...

Novartis has named its new Chief Financial Officer, Mehta, as part of management updates. The Swiss pharma company slightly raised its full-year sales guidance despite reporting Q2 sales figures...